Inventor
Roberta Cannella
Inventor
Varese, IT
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes31%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations23%
B65BMachines, apparatus or devices for, or methods of, packaging articles or materials17%
A61JContainers specially adapted for medical or pharmaceutical purposes8%
C07DHeterocyclic compounds7%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests6%
LOC281%
PatentTitleYear
10,828,297Compositions and methods for treating centrally mediated nausea and vomiting202010,717,721Substituted piperaziniums for the treatment of emesis202010,624,911Physiologically balanced injectable formulations of fosnetupitant202010,208,073Solution comprising the chloride hydrochloride salt of 4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-IUM-(fosnetupitant) and palonosetron hydrochloride in combination with dexamethasone as a neurokinin receptor modulator20199,943,515Compositions and methods for treating centrally mediated nausea and vomiting20189,908,907'Substituted piperaziniums for the treatment of emesis'20189,457,021'Liquid pharmaceutical formulations of palonosetron'20169,457,020'Liquid pharmaceutical formulations of palonosetron'20169,439,854'Liquid pharmaceutical formulations of palonosetron'20169,403,772'4-(5-(2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethylpropanamido)-4-(o-tolyl)pyridin-2-yl)-1-methyl-1-((phosphonooxy)methyl)piperazin-1-ium as a neurokinin receptor modulator'20169,308,266'Liquid pharmaceutical formulations of palonosetron'20169,271,975'Compositions and methods for treating centrally mediated nausea and vomiting'20169,186,357'Compositions and methods for treating centrally mediated nausea and vomiting'20159,173,942'Liquid pharmaceutical formulations of palonosetron'20159,125,905'Liquid pharmaceutical formulations of palonosetron'20159,066,980'Liquid pharmaceutical formulations of palonosetron'20158,951,969'Compositions and methods for treating centrally mediated nausea and vomiting'20158,895,586'Methods of treating emesis'20148,729,094'Liquid pharmaceutical formulations of palonosetron'20148,623,826'Compositions and methods for treating centrally mediated nausea and vomiting'20148,598,218'Liquid pharmaceutical formulations of palonosetron'20138,598,219'Liquid pharmaceutical formulations of palonosetron'20138,518,981'Liquid pharmaceutical formulations of palonosetron'20138,426,450'Substituted 4-phenyl pyridines having anti-emetic effect'2013D0665072'Capsule for pharmaceutical products'20127,960,424'Liquid pharmaceutical formulations of palonosetron'20117,947,725'Liquid pharmaceutical formulations of palonosetron'20117,947,724'Liquid pharmaceutical formulations of palonosetron'2011Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2011–2020Patents assigned to HELSINN HEALTHCARE SA (27)· patent assignee history
2011–2016Patents assigned to ROCHE PALO ALTO LLC (12)· patent assignee history
2011–2020Based in Varese, IT· patent location history
2012–2014Patents assigned to CANNELLA ROBERTA (5)· patent assignee history
2013–2015Patents assigned to MACCIOCCHI GIULIO (6)· patent assignee history
2013–2015Patents assigned to MACCIOCCHI SIMONE (6)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| HELSINN HEALTHCARE SA | 27 | 2011–2020 |
| ROCHE PALO ALTO LLC | 12 | 2011–2016 |
| MACCIOCCHI GIULIO | 6 | 2013–2015 |
| MACCIOCCHI SIMONE | 6 | 2013–2015 |
| CANNELLA ROBERTAself | 5 | 2012–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Varese, IT | 28 | 2011–2020 |